Objective: To observe the expression changes of plasminogen activator inhibitor-1(PAI-1) and tissue inhibitor of metalloproteinase-1(TIMP-1) in kidney of diabetic nephropathy rats,and to explore the role of PAI-1 and TIMP-1 in the development of renal fibrosis of diabetic nephropathy(DP).
目的:动态观察纤溶酶原激活物抑制剂-1(PAI-1)和金属蛋白酶组织抑制因子-1(TIMP-1)在糖尿病大鼠肾脏中的表达,探讨PAI-1及TIMP-1在糖尿病肾病(DN)肾纤维化发生、发展过程中的作用。
参考来源 - 糖尿病大鼠肾脏PAI·2,447,543篇论文数据，部分数据来源于NoteExpress
血浆纤溶酶原激活物抑制剂(PAI) - 1是纤溶系统的主要调控因子。
Plasminogen activator inhibitor-1 (PAI-1) is the main regulator of the fibrinolytic system.
目的研究纤溶酶原激活物抑制剂(PAI1)与肝细胞癌(HCC)生物学特性的关系。
Objective to study the relationship between plasminogen activator inhibitor type 1 (PAI 1) and biological behaviour of hepatocellular carcinoma (HCC).
纤溶酶原激活物抑制剂1 (PAI - 1)是一种单链糖蛋白，起抑制纤溶活性的作用。
Plasminogen activator inhibitor-1 (PAI-1) is a single strand glycoprotein, which can inhibit plasminogen activation.
应用推荐